about
A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic markerUp-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma.Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents.Intratumoral administration of secondary lymphoid chemokine and unmethylated cytosine-phosphorothioate-guanine oligodeoxynucleotide synergistically inhibits tumor growth in vivo.The relation between c-myc expression and interferon sensitivity in uveal melanoma.Clinical outcome of 31 patients with primary malignant melanoma of the vagina.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
An update on adjuvant interferon for melanoma.
@ast
An update on adjuvant interferon for melanoma.
@en
An update on adjuvant interferon for melanoma.
@nl
type
label
An update on adjuvant interferon for melanoma.
@ast
An update on adjuvant interferon for melanoma.
@en
An update on adjuvant interferon for melanoma.
@nl
prefLabel
An update on adjuvant interferon for melanoma.
@ast
An update on adjuvant interferon for melanoma.
@en
An update on adjuvant interferon for melanoma.
@nl
P2093
P2860
P1433
P1476
An update on adjuvant interferon for melanoma.
@en
P2093
Barbara A Pockaj
John M Kirkwood
Richard J Gray
P2860
P356
10.1177/107327480200900103
P577
2002-01-01T00:00:00Z